A detailed history of Confluence Investment Management LLC transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Confluence Investment Management LLC holds 3,658 shares of RDY stock, worth $51,943. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,658
Previous 3,646 0.33%
Holding current value
$51,943
Previous $277,000 4.69%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$75.41 - $84.21 $904 - $1,010
12 Added 0.33%
3,658 $290,000
Q2 2024

Jul 01, 2024

SELL
$68.26 - $76.19 $5,733 - $6,399
-84 Reduced 2.25%
3,646 $277,000
Q1 2024

Apr 01, 2024

SELL
$67.36 - $77.59 $336 - $387
-5 Reduced 0.13%
3,730 $273,000
Q4 2023

Nov 05, 2024

BUY
$64.27 - $69.9 $4,948 - $5,382
77 Added 2.1%
3,735 $259,000
Q3 2023

Oct 10, 2023

SELL
$61.9 - $72.77 $33,673 - $39,586
-544 Reduced 12.71%
3,735 $249,000
Q4 2022

Jan 03, 2023

BUY
$51.15 - $57.45 $2,404 - $2,700
47 Added 1.11%
4,279 $221,000
Q2 2022

Jul 12, 2022

SELL
$49.62 - $58.13 $2,183 - $2,557
-44 Reduced 1.03%
4,232 $234,000
Q1 2022

Apr 04, 2022

SELL
$48.27 - $65.25 $30,989 - $41,890
-642 Reduced 13.05%
4,276 $238,000
Q4 2021

Jan 04, 2022

SELL
$59.5 - $67.25 $13,863 - $15,669
-233 Reduced 4.52%
4,918 $322,000
Q3 2021

Oct 04, 2021

BUY
$60.19 - $75.29 $2,407 - $3,011
40 Added 0.78%
5,151 $336,000
Q2 2021

Jul 01, 2021

SELL
$62.12 - $74.2 $14,039 - $16,769
-226 Reduced 4.23%
5,111 $376,000
Q1 2021

Apr 05, 2021

BUY
$57.98 - $73.08 $3,594 - $4,530
62 Added 1.18%
5,337 $327,000
Q4 2020

Jan 25, 2021

SELL
$62.61 - $71.29 $7,262 - $8,269
-116 Reduced 2.15%
5,275 $376,000
Q3 2020

Oct 19, 2020

SELL
$51.39 - $72.41 $4,368 - $6,154
-85 Reduced 1.55%
5,391 $375,000
Q2 2020

Jul 01, 2020

BUY
$39.55 - $54.65 $216,575 - $299,263
5,476 New
5,476 $290,000

Others Institutions Holding RDY

About DR REDDYS LABORATORIES LTD


  • Ticker RDY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 166,028,992
  • Market Cap $2.36B
  • Description
  • Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...
More about RDY
Track This Portfolio

Track Confluence Investment Management LLC Portfolio

Follow Confluence Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Confluence Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Confluence Investment Management LLC with notifications on news.